{
"@context": "https://schema.org",
"@type": "Article",
"headline": "FDA Maintains Focus on “Intended Use” for Software-Enabled Medical Devices",
"url": "https://www.lexblog.com/2023/07/26/fda-maintains-focus-on-intended-use-for-software-enabled-medical-devices/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-W5X0FCAD",
"url": "https://www.lexblog.com/lib/W5X0FCAD/"
},
"datePublished": "2023-07-26T12:38:23-04:00",
"dateModified": "2023-07-26T09:39:04-04:00",
"author": {
"@type": "Person",
"name": "Dominick DiSabatino, Audrey Mercer, Julian Klein"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Sheppard, Mullin, Richter & Hampton LLP"
},
"organizationScope": "at-publication",
"about": "Health Care and Life Sciences",
"sourceUrl": "https://www.fdalawblog.com/?p=2090",
"sourceStability": "may-move"
}